Unicycive Therapeutics, Inc. - Common Stock, $0.001 par value per share (UNCY) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
UNCY on Nasdaq
Shares outstanding
24,093,727
Price per share
$6.67
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
8,144,623
Total reported value
$47,021,122
% of total 13F portfolios
0%
Share change
+1,782,956
Value change
+$10,346,527
Number of holders
34
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Unicycive Therapeutics, Inc. - Common Stock, $0.001 par value per share (UNCY) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vivo Opportunity Fund Holdings, L.P. 10% $26,579,323 6,096,175 Vivo Opportunity Fund Holdings, L.P. 30 Sep 2025
RA CAPITAL MANAGEMENT, L.P. 9.9% 0% $14,001,588 +$2,495,038 2,385,279 +22% RA Capital Management, L.P. 31 Dec 2025
Nantahala Capital Management, LLC 10% $13,389,705 2,281,040 Nantahala Capital Management, LLC 31 Dec 2025
BIOTECHNOLOGY VALUE FUND L P 10% $7,439,864 1,417,117 BVF PARTNERS L P/IL 30 Jun 2025
INTEGRATED CORE STRATEGIES (US) LLC 5.5% $6,555,209 1,172,667 Integrated Core Strategies (US) LLC 16 Jan 2026
Octagon Capital Advisors LP 4.7% -17% $5,870,000 1,000,000 0% Octagon Capital Advisors LP 31 Dec 2025
GREAT POINT PARTNERS LLC 4.5% -29% $3,472,993 796,558 0% Great Point Partners, LLC 30 Sep 2025

As of 31 Dec 2025, 34 institutional investors reported holding 8,144,623 shares of Unicycive Therapeutics, Inc. - Common Stock, $0.001 par value per share (UNCY). This represents 34% of the company’s total 24,093,727 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Unicycive Therapeutics, Inc. - Common Stock, $0.001 par value per share (UNCY) together control 34% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Vivo Capital, LLC 7.4% 1,789,916 0% 0.67% $10,327,815
MILLENNIUM MANAGEMENT LLC 4.2% 1,014,843 0% $5,855,644
Octagon Capital Advisors LP 4.2% 1,000,000 0% 0.72% $5,770,000
Nantahala Capital Management, LLC 3.9% 939,202 0% 0.32% $5,419,196
GREAT POINT PARTNERS LLC 3.3% 796,558 0% 1.5% $4,596,140
VANGUARD GROUP INC 3.3% 788,587 +20% 0% $4,550,147
Logos Global Management LP 2% 473,563 0% 0.18% $2,732,459
CITADEL ADVISORS LLC 1.1% 258,301 +520% 0% $1,490,397
CANTOR FITZGERALD, L. P. 0.83% 200,000 0.03% $1,154,000
GEODE CAPITAL MANAGEMENT, LLC 0.71% 171,290 +36% 0% $989,213
BNP PARIBAS FINANCIAL MARKETS 0.41% 99,742 0% 0% $575,511
Dauntless Investment Group, LLC 0.37% 89,415 2.1% $515,925
OMERS ADMINISTRATION Corp 0.32% 78,200 0% $451,214
STATE STREET CORP 0.27% 65,227 +19% 0% $376,360
ACUTA CAPITAL PARTNERS, LLC 0.25% 59,985 0% 0.23% $346,113
Squarepoint Ops LLC 0.23% 55,305 -53% 0% $319,110
MORGAN STANLEY 0.19% 46,584 +339% 0% $268,790
Quadrature Capital Ltd 0.16% 39,114 0% $225,688
BlackRock, Inc. 0.15% 36,355 0% 0% $209,768
NORTHERN TRUST CORP 0.15% 35,937 +9.9% 0% $207,356
XTX Topco Ltd 0.15% 35,405 -6.4% 0.01% $204,287
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.1% 24,931 0% $143,852
Chicago Partners Investment Group LLC 0.09% 22,413 -17% 0% $155,098
UBS Group AG 0.08% 19,905 +266% 0% $114,852
Tower Research Capital LLC (TRC) 0.01% 1,920 0% $11,078

Institutional Holders of Unicycive Therapeutics, Inc. - Common Stock, $0.001 par value per share (UNCY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 8,144,623 $47,021,122 +$10,346,527 $5.77 34
2025 Q3 6,285,927 $27,416,349 +$4,969,640 $4.36 30
2025 Q2 5,144,083 $24,616,897 +$24,616,897 $4.77 19